Shares of Ensign Group, Inc (NASDAQ:ENSG) are trading lower Monday morning after Hunterbrook Media published a short report accusing the skilled nursing operator of potential fraud and dangerous understaffing. Benzinga has reached out to Ensign Group for comment on the allegations.

Allegations of Illegal Understaffing And Profit Maximization

According to the five-month investigation, Ensign’s $10 billion empire relies on a business model that intentionally understaffs facilities to maximize government payouts. Hunterbrook alleges that between July and November 2024, Ensign facilities provided 5 million fewer nursing hours than what was clinically necessary.

Per Hunterbrook, this staffing gap reportedly saved the company roughly $161 million during that five-month period, which annualizes to more than its total reported net income for 2024.

Alleged Manipulation Of CMS Star Ratings And “Tunneling” Schemes

Hunterbrook alleged that Ensign routinely violated state minimum staffing laws across California, Kansas, Tennessee and Washington. Furthermore, the report argues the company artificially inflates its highly touted Centers for Medicare & Medicaid Services “star ratings” by manipulating self-reported data, despite scoring poorly on independent government evaluations.

Finally, Hunterbrook highlights questionable financial maneuvers, alleging Ensign “tunneled” over $339 million, roughly 8% of its 2024 revenue, to its own corporate affiliates to obscure profits. The report points to the tragic real-world consequences of this alleged corporate neglect, citing severe patient harm and preventable deaths at various facilities.

ENSG Shares Slide Monday Morning

ENSG Price Action: Ensign Group shares were down 7.07% at $158.49 at the time of publication on Monday, according to Benzinga Pro data.

Image: Shutterstock